Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial.
Muresanu DF, Heiss WD, Hoemberg V, Bajenaru O, Popescu CD, Vester JC, Rahlfs VW, Doppler E, Meier D, Moessler H, Guekht A · 2016 · Stroke
What does this source report?
The exploratory trial reports better upper-limb motor recovery at day 90.
- Population and setting
- Stroke patients receiving standardized rehabilitation; CARS trial
- Evidence type
- Randomized trial
- Preparation
- Porcine brain-derived peptide mixture; equivalence to other hydrolysates is not assumed
- Source language
- Indexed English abstract; original language varies
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Authors call for a larger confirmatory trial. Rehabilitation and timing define the setting; this is not evidence of healthy-person enhancement.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Citation and indexed abstract checked. Full methods, funding and risk of bias have not been comprehensively appraised.
Recorded source-check date: 2026-09-30. This date does not imply a completed systematic review.
Source provenance: Journal publication
Cite and trace this record
Original source: Muresanu DF, Heiss WD, Hoemberg V, Bajenaru O, Popescu CD, Vester JC, Rahlfs VW, Doppler E, Meier D, Moessler H, Guekht A. Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial. Stroke 2016.
Molekul research summary: https://molekul.io/research/cbl-26564102. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry